Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
6
7
9
10
11
12
13
14
18
19
20
21
23
27
28
30
12:00 AM - Hepatology 2021
31
1
2
3
4
Heart Care and Diseases 2021
2021-03-03    
All Day
Euro Heart Conference 2020 will join world-class professors, scientists, researchers, students, Perfusionists, cardiologists to discuss methodology for ailment remediation for heart diseases, Electrocardiography, Heart Failure, [...]
Gastroenterology and Digestive Disorders
2021-03-04 - 2021-03-05    
All Day
Gastroenterology Diseases is clearing a worldwide stage by drawing in 2500+ Gastroenterologists, Hepatologists, Surgeons going from Researchers, Academicians and Business experts, who are working in [...]
Environmental Toxicology and Ecological Risk Assessment
2021-03-04 - 2021-03-05    
All Day
Environmental Toxicology 2021 you can meet the world leading toxicologists, biochemists, pharmacologists, and also the industry giants who will provide you with the modern inventions [...]
Dermatology, Cosmetology and Plastic Surgery
2021-03-05 - 2021-03-06    
All Day
Market Analysis Speaking Opportunities Speaking Opportunities: We are constantly intrigued by hearing from professionals/practitioners who want to share their direct encounters and contextual investigations with [...]
World Dental Science and Oral Health Congress
2021-03-08 - 2021-03-09    
All Day
About The Webinar Conference Series LLC Ltd invites you to attend the 42nd World Dental Science and Oral Health Congress to be held in March 08-09, 2021 with the [...]
Euro Metabolomics & Systems Biology
2021-03-08 - 2021-03-09    
All Day
Euro Metabolomics 2021 will be a platform to investigate recent research and advancements that can be useful to the researchers. Metabolomics is a rapidly emerging [...]
International Summit on Industrial Engineering
2021-03-15 - 2021-03-16    
All Day
Industrial Engineering conference invites all the participants to attend International summit on Industrial Engineering during March15-16, 2021 Webinar. This has prompt keynotes, Oral talks, Poster [...]
Digital Health 2021
2021-03-15 - 2021-03-16    
All Day
The use of modern technologies and digital services is not only changing the way we communicate, they also offer us innovative ways for monitoring our [...]
Genetics and Molecular biology 2021
2021-03-15    
All Day
Human genetics is study of the inheritance of characteristics by children from parents. Inheritance in humans does not differ in any fundamental way from that [...]
Food Science and Food Safety
2021-03-16 - 2021-03-17    
All Day
Food Safety. It also provides the premier multidisciplinary forum for researchers, professors and educators to present and discuss the most recent innovations, trends, and concerns, [...]
Traditional and Alternative Medicine
2021-03-16 - 2021-03-17    
All Day
Traditional Medicine 2021 welcomes attendees, presenters, and exhibitors from all over the world. We are glad to invite you all to attend and register for [...]
Carbon and Advanced Energy Materials
2021-03-16 - 2021-03-17    
All Day
Materials Science 2021 was an enchanted achievement. We give incredible credits to the Organizing Committee and participants of Materials Science 2021 Conference. Numerous tributes from [...]
Advancements in Tuberculosis and Lung Diseases
2021-03-17 - 2021-03-18    
All Day
Tuberculosis is a communicable disease, caused by the infectious bacterium Mycobacterium tuberculosis. It affects the lungs and other parts of the body (brain, spine). People [...]
Herbal Medicine and Acupuncture 2021
2021-03-22 - 2021-03-23    
All Day
The event offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and [...]
Hospital Management and Health Care
2021-03-22 - 2021-03-23    
All Day
Healthcare system refers to the totality of resource that a society distributes with in organization and health facilities delivery for the aim of upholding or [...]
Hematology and Infectious Diseases
2021-03-22 - 2021-03-23    
All Day
Hematology is the discipline concerned with the production, functions, bone marrow, and diseases which are related to blood, blood proteins. The main aim of this [...]
Aquaculture & Marine Biology
2021-03-24 - 2021-03-25    
All Day
The 15th International Conference on Aquaculture & Marine Biology is delighted to welcome the participants from everywhere the planet to attend the distinguished conference scheduled [...]
Artificial Intelligence & Robotics 2021
2021-03-24 - 2021-03-25    
All Day
The Conference Series LLC Ltd organizes conferences around the world on all computer science subjects including Robotics and its related fields. Here we are happy [...]
Tissue Engineering & Regenerative Medicine
2021-03-24 - 2021-03-25    
All Day
Tissue Engineering & Regenerative Medicine mainly focuses on Stem Cell Research and Tissue Engineering. Stem cell Research includes stem cell treatment for various disease and [...]
Nursing Research and Evidence Based Practice
2021-03-25 - 2021-03-26    
12:00 am
Global Nursing Practice 2021 has been circumspectly organized with various multi and interdisciplinary tracks to accomplish the middle objective of the gathering that is to [...]
Earth & Environmental Science 2021
2021-03-26 - 2021-03-27    
All Day
Earth Science 2021 is the integration of new technologies in the field of environmental science to help Environmental Professionals harness the full potential of their [...]
Earth & Environmental Science 2021
2021-03-26 - 2021-03-27    
All Day
Earth Science 2021 is the integration of new technologies in the field of environmental science to help Environmental Professionals harness the full potential of their [...]
Nanomaterials and Nanotechnology
2021-03-26 - 2021-03-27    
All Day
Nanomaterials are the elements which have at least one spatial measurement in the size range of 1 to 100 nanometre. Nanomaterials can be produced with [...]
Smart Materials and Nanotechnology
2021-03-29 - 2021-03-30    
All Day
Smart Material 2021 clears a stage to globalize the examination by introducing an exchange amongst ventures and scholarly associations and information exchange from research to [...]
World Nanotechnology Congress 2021
2021-03-29    
All Day
Nano Technology Congress 2021 provides you with a unique opportunity to meet up with peers from both academic circle and industries level belonging to Recent [...]
Nanomedicine and Nanomaterials 2021
2021-03-29    
All Day
NanoMed 2021 conference provides the best platform of networking and connectivity with scientist, YRF (Young Research Forum) & delegates who are active in the field [...]
Hepatology 2021
2021-03-30 - 2021-03-31    
All Day
Hepatology 2021 provides a great platform by gathering eminent professors, Researchers, Students and delegates to exchange new ideas. The conference will cover a wide range [...]
Events on 2021-03-03
Events on 2021-03-05
Events on 2021-03-17
Events on 2021-03-25
Events on 2021-03-30
Hepatology 2021
30 Mar 21
Latest News

Universal Health Services, Inc. Reports 2016 First Quarter Financial Results

Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $190.8 million, or $1.93 per diluted share, during the first quarter of 2016 as compared to $174.3 million, or $1.73 per diluted share, during the comparable quarter of 2015.  Net revenues increased 10.1% to $2.45 billion during the first quarter of 2016 as compared to $2.23 billion during the first quarter of 2015.

For the three-month period ended March 31, 2016, our adjusted net income attributable to UHS per diluted share, as calculated on the attached Schedule of Non-GAAP Supplemental Consolidated Statements of Income Information (“Supplemental Schedule”), increased approximately 11% to $1.98 per diluted share, as compared to $1.78 per diluted share during the first quarter of 2015.  As reflected on the Supplemental Schedule, included in our reported results during each of the first quarters of 2016 and 2015, are net unfavorable after-tax impacts of $.05 per diluted share related to the depreciation and amortization expense recorded in connection with the implementation of electronic health records (“EHR”) applications at our acute care hospitals.

Acute Care Services – Three-month periods ended March 31, 2016 and 2015:
During the first quarter of 2016, at our acute care hospitals owned during both periods (“same facility basis”), adjusted admissions (adjusted for outpatient activity) increased 7.8% and adjusted patient days increased 3.5%, as compared to the first quarter of 2015. Net revenues at these facilities increased 12.0% during the first quarter of 2016 as compared to the first quarter of the prior year. At these facilities, net revenue per adjusted admission increased 3.0% while net revenue per adjusted patient day increased 7.3% during the first quarter of 2016 as compared to the comparable quarter of 2015. On a same facility basis, the operating margin at our acute care hospitals increased to 21.1% during the first quarter of 2016 as compared to 20.5% during the first quarter of 2015. We define operating margin as net revenues less salaries, wages and benefits, other operating expenses and supplies expense (excluding the impact of EHR and other items, if applicable, as indicated on the Supplemental Schedules).

We provide care to patients who meet certain financial or economic criteria without charge or at amounts substantially less than our established rates. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in net revenues or in accounts receivable, net. Our acute care hospitals provided charity care and uninsured discounts, based on gross charges, amounting to approximately $345 million and $287 million during the three-month periods ended March 31, 2016 and 2015, respectively. The provision for doubtful accounts at our acute care hospitals amounted to approximately $140 million and $124 million during the three-month periods ended March 31, 2016 and 2015, respectively. Our acute care hospitals experienced an increase in the aggregate of charity care, uninsured discounts and provision for doubtful accounts, as a percentage of gross charges, during the first quarter of 2016, as compared to the first quarter of 2015.

Behavioral Health Care Services – Three-month periods ended March 31, 2016 and 2015:
During the first quarter of 2016, at our behavioral health care facilities on a same facility basis, adjusted admissions increased 1.4% while adjusted patient days increased 1.0% as compared to the first quarter of 2015. At these facilities, net revenue per adjusted admission increased 1.8% while net revenue per adjusted patient day increased 2.2% during the first quarter of 2016 as compared to the comparable quarter in 2015. On a same facility basis, our behavioral health services’ net revenues increased 3.5% during the first quarter of 2016, as compared to the comparable quarter in 2015. The operating margins were 27.8% during the first quarter of 2016 and 28.4% during the first quarter of 2015.

Share Repurchase Program:
In February of 2016, our Board of Directors authorized a $400 million increase to our stock repurchase program, which increased the aggregate authorization to $800 million from the previous $400 million authorization approved during the third quarter of 2014.  Pursuant to this program, we may purchase shares of our Class B Common Stock, from time to time as conditions allow, on the open market or in negotiated private transactions.

In conjunction with this program, during the first quarter of 2016, we repurchased approximately 1.3 million shares at an aggregate cost of $152.4 million (approximately $113 per share).  Since inception of the program through March 31, 2016, we repurchased approximately 3.2 million shares at an aggregate cost of approximately $376.6 million (approximately $117 per share).

Conference call information:
We will hold a conference call for investors and analysts at 9:00 a.m. eastern time on April 28, 2016. The dial-in number is 1-877-648-7971.

A live broadcast of the conference call will be available on our website at www.uhsinc.com.  A replay of the call will be available following the conclusion of the live call and will be available for one full year.

General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:
Universal Health Services, Inc. (“UHS”) is one of the nation’s largest hospital companies operating through its subsidiaries acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, Puerto Rico and the U.S. Virgin Islands.  It acts as the advisor to Universal Health Realty Income Trust, a real estate investment trust (NYSE: UHT).  For additional information on the Company, visit our web site: http://www.uhsinc.com.

This press release contains forward-looking statements based on current management expectations.  Numerous factors, including those disclosed herein, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1ARisk Factors and in Item 7-Forward-Looking Statements and Risk Factors in our Form 10-K for the year ended December 31, 2015), may cause the results to differ materially from those anticipated in the forward-looking statements.  Many of the factors that will determine our future results are beyond our capability to control or predict. These statements are subject to risks and uncertainties and therefore actual results may differ materially.  Readers should not place undue reliance on such forward-looking statements which reflect management’s view only as of the date hereof.  We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

We believe that operating income, operating margin, adjusted net income attributable to UHS, adjusted net income attributable to UHS per diluted share and earnings before interest, taxes, depreciation and amortization (“EBITDA”), which are non-GAAP financial measures (“GAAP” is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect in each year of material items related to the implementation of EHR applications at our acute care hospitals and other items that are nonrecurring or non-operational in nature including, but not limited to, costs related to extinguishment of debt, gains on sales of assets and businesses, reserves for settlements, legal judgments and lawsuits, impairments of long-lived assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods.  To obtain a complete understanding of our financial performance these measures should be examined in connection with net income, determined in accordance with GAAP, as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2015. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability.  Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies.  Investors are encouraged to use GAAP measures when evaluating our financial performance.

Our acute care hospitals are eligible for Medicare and Medicaid EHR incentive payments upon implementation of the EHR application, once they have demonstrated meaningful use of certified EHR technology for the applicable stage or have completed attestations to their adoption or implementation of certified EHR technology.  However, there may be timing differences in the recognition of the incentive income and expenses recorded in connection with the implementation of the EHR application which may cause material period-to-period changes in our future results of operations. Pursuant to regulations, hospitals that did not qualify as a meaningful user of EHR by 2015 are subject to a reduced market basket update to the inpatient prospective payment system standardized amount in 2015 and each subsequent fiscal year. We believe that all of our acute care hospitals have met the applicable meaningful use criteria and therefore are not subject to a reduced market basked update to the inpatient prospective payment standardized amount. Under the HITECH Act, hospitals must continue to meet the applicable meaningful use criteria in each fiscal year or they will be subject to a market basket update reduction in a subsequent fiscal year.

Universal Health Services, Inc.

Consolidated Statements of Income

(in thousands, except per share amounts)

(unaudited)

Three months

ended March 31,

2016

2015

Net revenues before provision for doubtful accounts

$2,619,593

$2,380,101

  Less: Provision for doubtful accounts

169,795

154,748

Net revenues

2,449,798

2,225,353

Operating charges:

   Salaries, wages and benefits

1,148,139

1,031,703

   Other operating expenses

561,584

505,966

   Supplies expense

255,250

238,741

   Depreciation and amortization

104,049

98,998

   Lease and rental expense

24,452

22,891

2,093,474

1,898,299

Income from operations

356,324

327,054

Interest expense, net

29,600

30,037

Income before income taxes

326,724

297,017

Provision for income taxes

111,005

102,694

Net income

215,719

194,323

Less:  Income attributable to

noncontrolling interests

24,960

20,024

Net income attributable to UHS

$190,759

$174,299

Basic earnings per share attributable to UHS (a)

$1.95

$1.76

Diluted earnings per share attributable to UHS (a)

$1.93

$1.73

 

 

Universal Health Services, Inc.

 Source